Hence, clinical recurrence (CLR) in PCa was linked to changes in the TME in several studies [8–12], including reports on CLR-dependent alterations in expression profiles of steroid hormone receptors (SHR) [13–16], cancer activated fibroblast (CAF) markers [17, 18] and vascular markers. Here, DCLK3 is linked to posterior cortical atrophy.